Background: Although there is clear evidence that therapeutic drug monitoring (TDM) has beneficial effects for patients treated with tricyclic antidepressants, it is generally not recommended for second-generation antidepressants (SGA). However, it has been suggested that methodological shortcomings might influence the results in TDM studies with SGA.
Aim: A qualitative assessment of randomized controlled trials (RCTs) that specifically investigated drug concentration-effect relationships of SGA in patients with major depressive disorder (MDD) to analyze the potential benefit of TDM during treatment with these agents.
Background: Psychiatry may currently hold unprecedented knowledge in the diagnosis and treatment of psychiatric conditions. Yet, there is a widely held belief that this knowledge is not adequately integrated, nor does it fully account for the complexity of the phenomena under study.
Objective: To assess the effectiveness of a system-oriented and network-focused approach in capturing and integrating the complexity of psychiatric disorders.
Background: While theta burst stimulation (TBS) shows promise in Major Depressive Disorder (MDD), its effectiveness in bipolar depression (BD-D) remains uncertain. Optimizing treatment parameters is crucial in the pursuit of rapid symptom relief. Moreover, aligning with personalized treatment strategies and increased interest in immunopsychiatry, biomarker-based stratification of patients most likely to benefit from TBS might improve remission rates.
View Article and Find Full Text PDF